1-4 of 4
Agnès Veyradier
Close
Sort by
Journal Articles

Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience

Nicolas Béranger, Paul Coppo, Vassilis Tsatsaris, Pierre Boisseau, François Provôt, Yahsou Delmas, Pascale Poullin, Karen Vanhoorelbeke, Agnès Veyradier, Bérangère S. Joly
Journal: Blood Advances
Blood Adv (2023) 8 (1): 183–193.
https://doi.org/10.1182/bloodadvances.2023011972
Published: 2023
Includes: Supplemental data
Journal Articles

More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura

Adrien Picod, Ygal Benhamou, Raïda Bouzid, Agnès Veyradier, Paul Coppo
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2678–2680.
https://doi.org/10.1182/bloodadvances.2022009021
Published: 2023
Journal Articles

Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP

Laure De Waele, Alexandre Curie, Kadri Kangro, Edwige Tellier, Gilles Kaplanski, Andres Männik, Claudia Tersteeg, Bérangère S. Joly, Paul Coppo, Agnès Veyradier, Simon F. De Meyer, Elien Roose, Karen Vanhoorelbeke
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4480–4484.
https://doi.org/10.1182/bloodadvances.2021004971
Published: 2021
Journal Articles

Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura

Kadri Kangro, Elien Roose, Bérangère S. Joly, György Sinkovits, Tanja Falter, Charis von Auer, Heidi Rossmann, Marienn Reti, Jan Voorberg, Zoltán Prohászka, Bernhard Lämmle, Paul Coppo, Agnès Veyradier, Simon F. De Meyer, Andres Männik, Karen Vanhoorelbeke
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3427–3435.
https://doi.org/10.1182/bloodadvances.2020004172
Published: 2021
Includes: Supplemental data